GemOx


GemOx or GEMOX is an acronym for one of the chemotherapy regimens used in the treatment of relapsed or primary refractory non-Hodgkin's lymphoma and Hodgkin's lymphoma.
When combined with Rituximab it is called R-GemOx, R-GEMOX or GemOx-R, GEMOX-R.
The -GemOx regimen consists of:
  1. 'ituximab - anti-CD20 monoclonal antibody that has the ability to kill both normal and malignant B cells;
  2. 'citabine - an antimetabolite;
  3. aliplatin - a platinum-based alkylating antineoplastic agent.

    Dosing regimen